WELITEL-AMH combines Telmisartan 40 mg + Hydrochlorothiazide 12.5 mg + Amlodipine 5 mg, providing a comprehensive triple-mechanism approach for patients requiring intensified BP management. An important PCD Cardiac-Diabetic product.
When BP remains inadequately controlled with fewer medicines.
Yes.
Regular BP and clinical monitoring may be advised.
Take consistently and monitor BP. Report significant edema, severe dizziness, weakness or palpitations.
Dizziness, ankle edema, increased urination, electrolyte imbalance, headache and fatigue.
WELITEL-AMH: Telmisartan blocks angiotensin II, Amlodipine produces vasodilation and Hydrochlorothiazide promotes fluid excretion, providing three complementary antihypertensive mechanisms.
